Janchor Partners
Overview
Janchor Partners is a long-term industrialist investor headquartered in Hong Kong, partnering with companies that have superior business models, favorable growth prospects and the potential to be part of long-term positive structural dynamics of Asian countries and economies . As a genuine thought partner with its investee companies, Janchor Partners helps to increase long-term corporate value and builds strong long-term relationships with them . Janchor's mission as an Industrialist Investor is anchored by its purpose to have a lasting impact through deep relationships by building insight and trust .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Beijing Safe Pharmaceutical Technology Co., Ltd. | Feb 2021 | IPO | Co-investor |
| Rokt | Jan 2025 | Secondary | Co-investor |
| Everest Medicines | Oct 2020 | IPO | Co-investor |
| RemeGen | Mar 2020 | Private Equity | Co-investor |
| MediTrust Health | Aug 2021 | Series C | Lead |
For institutional investors. Book with your work email.
Key People
John Ho
Founder And Chief Industrialist Investor
Genny Chin
Investment Partner Communications
Shirley T.
Business Development Investment Partner Communications
Calvin Chung
Industrialist Investor Trading
James Gunn
Industrialist Investor
Kelly C.
Industrialist Investor Trader Recruiter
Rei Ogasawara
Industrialist Investor
Tian Ren
Industrialist Investor
Yubo Gong
Industrialist Investor
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Janchor Partners based?
Janchor Partners is headquartered in Hong Kong, Hong Kong, Hong Kong.
When was Janchor Partners founded?
Janchor Partners was founded in 2009.
How many portfolio companies does Janchor Partners have?
Janchor Partners has 11 portfolio companies in Caplight's dataset.
What are some companies in Janchor Partners's portfolio?
Portfolio companies visible on Caplight include Beijing Safe Pharmaceutical Technology Co., Ltd., Rokt, Everest Medicines, RemeGen, MediTrust Health.
What was Janchor Partners's most recent investment shown here?
Janchor Partners's most recent investment in this portfolio sample was in Rokt in 2025.
What sectors does Janchor Partners focus on?
Janchor Partners focuses on Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, FinTech, Healthcare & Life Sciences, FinTech, Healthcare & Life Sciences, Consumer & Commerce, Consumer & Commerce, FinTech, Healthcare & Life Sciences, FinTech, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech.
What company stages does Janchor Partners focus on?
Janchor Partners typically invests at the Mid stage.
What is Janchor Partners's AUM?
Janchor Partners's assets under management are estimated between $1.0B and $10.0B.